| Primary information |
|---|
| ID | antitb_1270 |
| Peptide Name | VapC30 (48-56) |
| Sequence | RFGEPGGRE |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 9 |
| Chirality | L |
| Nature | NA |
| Source | Protein Derived |
| Origin | From VapC30 toxin |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis (strain H37Rv) |
| Inhibition Concentartion | NA |
| In vitro/In vivo | NA |
| Cell Line | NA |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | None |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | By disrupting the toxin-antitoxin complex (VapBC) |
| Target | VapBC |
| Combination Therapy | None |
| Other Activities | NA |
| Pubmed ID | 26150422 |
| Year of Publication | 2015 |
| 3-D Structure |  View in Jmol or Download Structure |